Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?
- PMID: 27614938
- DOI: 10.1016/j.jchf.2016.07.013
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?
Keywords: angiotensin receptor blocker; angiotensin receptor-neprilysin inhibitor; angiotensin-converting-enzyme inhibitor; cardiovascular mortality; left ventricular ejection fraction.
Comment on
-
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial.JACC Heart Fail. 2016 Oct;4(10):816-822. doi: 10.1016/j.jchf.2016.05.002. Epub 2016 Jul 6. JACC Heart Fail. 2016. PMID: 27395349 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical